Clinical Trial Update: Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis [Phase 4]

View source ↗

Summary

This Phase 4 trial update evaluates using dupilumab with a step-down strategy to maintain remission in adults and adolescents with atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Nantes University Hospital | Conditions: Atopic Dermatitis, Eczema, Atopic | Phase 4 | Status: ACTIVE_NOT_RECRUITING